Hormones and the health of women: Past, present, and future keynote address

Menopause

Volumn 9, Issue 1, 2002, Pages 23-31

  Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hormone replacement therapy; Oral contraceptives; Sex hormones

Indexed keywords

AROMATASE INHIBITOR; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; NATURAL PRODUCT; ORAL CONTRACEPTIVE AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG USE; HORMONAL THERAPY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MEDICAL PRACTICE; ORAL CONTRACEPTION; PREGNANCY;

EID: 0036158031     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200201000-00005     Document Type: Conference Paper

References (47)

1. The dawn of hormone replacement therapy
2. The effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals
3. John Rock's error
4. Abortion surveillance at CDC: Creating public health light out of political heat
5. Family planning
6. Perspective: Reproductive endocrinology and human health in the 20th century - A personal retrospective
7. Woman
8. At last, Japan gets the pill. Is this good news?
9. Oral contraception: Past, present, and future perspectives
10. Ischemic stroke risk with oral contraceptives: A meta-analysis
11. Breast cancer and hormone contraceptives: Collaborative reanalysis of data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
12. Type 3 errors, pill scares, and the epidemiology of oral contraception and health
13. Effect of bilateral ovariectomy on coronaryartery disease and serum-lipid levels
14. Specific procedures for the elimination of the menopause
15. Estrogen replacement therapy and publicity. Ageing and estrogens
16. Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene
17. Initial findings leading to modifications of its research protocol
18. Estrogen replacement therapy I: A 10-year prospective study in the relationship to osteoporosis
19. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
20. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
21. Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease
22. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
23. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy
24. Estrogen replacement in women with previous breast cancer
25. Effects of estrogen progestin on mammographic parenchymal density
26. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study
27. Hormone replacement therapy and endometrial cancer risk: A metaanalysis
28. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
29. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study
30. Estrogen receptor null mice: What have we learned and where will they lead us?
31. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
32. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial
33. Intracrinology
34. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up
35. Urinary estrogen metabolites and breast cancer: A case-control study
36. Use of aromatase inhibitors in breast carcinoma
37. Scientists reveal project for pill that puts off menopause. Fertility - How stopping egg growth could slow the ageing process
38. Physician and scientist